Last C$3.05 CAD
Change Today -0.05 / -1.61%
Volume 34.1K
NTB On Other Exchanges
Symbol
Exchange
NASDAQ CM
Berlin
Toronto
As of 4:00 PM 05/21/13 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Henri Harland BSc Act, MBA

Chief Executive Officer, President, Director, Member of Disclosure Policy Committee and Member of Selection Committee, Neptune Technologies & Bioresources, Inc.
AgeTotal Calculated CompensationThis person is connected to 25 board members in 4 different organizations across 4 different industries.

See Board Relationships
60C$339,000
As of Fiscal Year 2012

Background*

Mr. Henri Harland, BSc Act, MBA has been the Chief Executive Officer and Corporate Secretary at NeuroBiopharm Inc. since 2008 and also serves as its President. Mr. Harland has been the Chief Executive Officer and President of Neptune Technologies & Bioresources Inc., since October 9, 1998. He founded Neptune on October 9, 1998. Mr. Harland serves as the Chief Executive Officer and President of Acasti Pharma, Inc., a subsidiary of Neptune Technologies. He serves as Secretary ...

Read Full Background

Corporate Headquarters*

225 Promende du Centropolis
Laval, Quebec H7T 0B3

Canada

Phone: 450-687-2262
Fax: 450-687-2272

Board Members Memberships*

1998-Present
Chief Executive Officer, President, Director, Member of Disclosure Policy Committee and Member of Selection Committee
1998-Present
Secretary, Director and Member of Executive Committee
2002-Present
Chief Executive Officer, President, Director, President of Neptune Technologies & Bioressources Inc, Chief Executive Officer of Neptune Technologies & Bioressources Inc and Director of Neptune Technologies & Bioressources Inc
2008-Present
Chief Executive Officer, President, Corporate Secretary, Director and Member of Corporate Governance Committee

Education*

MBA
Université Laval

Other Affiliations*

Annual Compensation*

SalaryC$230,000
Total Annual CompensationC$230,000

Stock Options*

Total Value of OptionsC$363,750
Total Number of Options375,000

Total Compensation*

Total Annual Cash CompensationC$339,000
Total Short Term CompensationC$230,000
Total Calculated CompensationC$339,000
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NTB:CN C$3.05 CAD -0.05

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Philip C. Mezey Chief Executive Officer, President and Director
Itron, Inc.
$500.0K
Richard A. Meeusen Chairman, Chief Executive Officer and President
Badger Meter Inc.
$967.2K
Simon A. Peckham Chief Executive Officer, Managing Director and Member of The Administrative Board
Elster Group SE
--
William E. Shell M.D.Chief Executive Officer, Chief Scientific Officer, Director and Member of Scientific Advisory Committee
Targeted Medical Pharma, Inc.
$450.0K
Compensation as of Fiscal Year 2012.

Post a JobJobs

View all jobs

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEPTUNE TECH & BIORESSOURCES, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.